Imaging of Valvular Heart Disease in Heart Failure

Tomaz Podlesnikar1, Victoria Delgado1, Jeroen J Bax1

  • 1Heart and Lung Centre, Department of Cardiology, Leiden University Medical Center Leiden, The Netherlands.

Cardiac Failure Review
|September 13, 2018
PubMed

Insights

Valvular heart disease (VHD) and heart failure (HF) often coexist, complicating diagnosis and treatment. Multimodality cardiovascular imaging aids in accurately diagnosing and managing these complex cardiac conditions.

Area of Science:

  • Cardiology
  • Medical Imaging

Background:

  • Valvular heart disease (VHD) and heart failure (HF) are increasingly prevalent in Western populations.
  • The co-existence of VHD and HF complicates diagnosis and therapeutic decision-making.
  • Accurate assessment of valve severity and cardiac function is crucial for patient management.

Purpose of the Study:

  • To review the role of multimodality cardiovascular imaging in diagnosing and treating patients with co-existing VHD and HF.
  • To highlight the importance of integrating various imaging techniques for comprehensive patient evaluation.

Main Methods:

  • Review of transthoracic echocardiography as a first-line imaging modality.
  • Discussion of advanced imaging techniques including 3D transesophageal echocardiography, cardiovascular magnetic resonance, and cardiac CT.
  • Emphasis on the integration of multimodality imaging for treatment planning.

Main Results:

  • Transthoracic echocardiography assesses left ventricular systolic function and valve dysfunction.
  • Advanced imaging modalities provide complementary information for complex cases.
  • Multimodality imaging integration is key for guiding interventions like transcatheter aortic valve repair/replacement.

Conclusions:

  • Multimodality cardiovascular imaging is essential for accurate diagnosis and effective management of patients with VHD and HF.
  • Integrating various imaging modalities improves therapeutic decision-making, particularly for transcatheter therapies.
  • This approach enhances patient outcomes in complex cardiac scenarios.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
952
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.8K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
903
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
348
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
983
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
330